ORIGINAL RESEARCH
Accepted on 12 Feb 2025
Rapamycin combined with Osimertinib alleviated non-small cell lung cancer by regulating the PARP, Akt/mTOR, and MAPK/ERK signaling pathways
doi 10.3389/fmolb.2025.1548810
- Frontiers in Molecular Biosciences
- Molecular Diagnostics and Therapeutics
- Research Topics
- Exploring and Overcoming Cancer Drug Resistance: Novel Insights and Strategies
Exploring and Overcoming Cancer Drug Resistance: Novel Insights and Strategies
247
Total downloads
1,874
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
Published in
Frontiers in Molecular Biosciences
- Molecular Diagnostics and Therapeutics
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.
Impact
- 1,874Topic views
- 731Article views
- 247Article downloads